Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

Delayed Quote. Delayed  - 05/04 04:40:34 pm
2.59 CHF   -0.38%
04/29 ADDEX THERAPEUT : Reports 2015 Financial Results
04/29 ADDEX THERAPEUT : Reports 2015 Financial Results
04/11 ADDEX THERAPEUT : Reports Positive Results of an mGlu5 Receptor Occu..
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
04/28/2016 04/29/2016 05/02/2016 05/03/2016 05/04/2016 Date
2.74(c) 2.73(c) 2.62(c) 2.6(c) 2.59 Last
8 497 4 701 40 966 20 004 5 001 Volume
+1.48% -0.36% -4.03% -0.76% -0.38% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company uses its proprietary discovery platform to address receptors and other proteins that are undruggable for conventional drug discovery methods, including G-protein coupled receptors, receptor... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
04/29 ADDEX THERAPEUTICS : Reports 2015 Financial Results
04/29 ADDEX THERAPEUTICS : Reports 2015 Financial Results
04/11 ADDEX THERAPEUTICS : Reports Positive Results of an mGlu5 Receptor Occupancy Stu..
03/15 ADDEX THERAPEUTICS : Reports Successful Completion of an mGlu5 Receptor Occupanc..
01/11 ADDEX THERAPEUTICS : Dipraglurant Shows Highly Statistically Significant Anti-Dy..
01/04 ADDEX THERAPEUTICS : ' Dipraglurant Receives Orphan Drug Designation from the FD..
2015 ADDEX THERAPEUTICS : Reports Statistically Significant Positive Interim Data for..
2015 ADDEX THERAPEUTICS : and University of Geneva Collaborators Awarded Swiss Grant ..
More news
Sector news : Biotechnology & Medical Research - NEC
06:01a ACTELION : Annual General Meeting of Shareholders held in Basel, Switzerland - A..
05/03 AMGEN : FDA Grants Priority Review For Amgen's Supplemental Biologics License Ap..
05/03DJPfizer Has Approached Medivation About Potential Acquisition -Reuters
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials